Savolitinib vs. Sunitinib in MET-driven PRCC.
AstraZeneca
AstraZeneca
CG Oncology, Inc.
Eli Lilly and Company
Astellas Pharma Inc
Eli Lilly and Company
Eli Lilly and Company
Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc.
Tyra Biosciences, Inc
CG Oncology, Inc.
Seagen Inc.
NiKang Therapeutics, Inc.
Tempus AI
Sichuan Baili Pharmaceutical Co., Ltd.
Lipac Oncology LLC